Clinical Trials for Mitochondrial Disease Heating Up with AMED’s Support; Filing for First Hyperlactacidemia Drug Expected in 2020

Investigator-initiated trials (IITs) supported by the Japan Agency for Medical Research and Development (AMED) are currently underway to develop treatments for mitochondrial disease, a designated intractable disease. An IIT of sodium pyruvate for hyperlactacidemia associated with mitochondrial disease is also...read more